{"id":"https://openalex.org/W2248506740","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7659","title":"Study of three weekly nab-paclitaxel regimens in combination with carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC)","display_name":"Study of three weekly nab-paclitaxel regimens in combination with carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC)","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2248506740","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7659","mag":"2248506740"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.7659","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7659","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.7659","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103887854","display_name":"Michael Hawkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. J. Hawkins","raw_affiliation_strings":["Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061692439","display_name":"G. Manikhas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Manikhas","raw_affiliation_strings":["Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058277804","display_name":"Anatoly N. Makhson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Makhson","raw_affiliation_strings":["Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090599068","display_name":"\u0427\u0435\u043f\u043e\u0440\u043e\u0432 \u0421\u0435\u0440\u0433\u0435\u0439 \u0412\u0430\u043b\u0435\u043d\u0442\u0438\u043d\u043e\u0432\u0438\u0447","orcid":"https://orcid.org/0000-0003-2776-4994","observed_orcids":["https://orcid.org/0000-0003-2776-4994"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Cheporov","raw_affiliation_strings":["Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005875420","display_name":"Sergey Orlov","orcid":"https://orcid.org/0000-0002-3134-1989","observed_orcids":["https://orcid.org/0000-0002-3134-1989"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Orlov","raw_affiliation_strings":["Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107930866","display_name":"P. K. Yablonsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Yablonsky","raw_affiliation_strings":["Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007531227","display_name":"Paul Bhar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Bhar","raw_affiliation_strings":["Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Socinski","raw_affiliation_strings":["Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abraxis Bioscience Inc, Los Angeles, CA; St. Petersburg Oncology Center, St. Petersburg, Russian Federation; City Oncology Hospital, Moscow, Russian Federation; Yaroslavl City Oncology Center, Yaroslavl, Russian Federation; St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation; City Multifield Hospital #2, Moscow, Russian Federation; University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"7659","last_page":"7659"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.6455000042915344,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.6455000042915344,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.3418000042438507,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.8809999823570251},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9369999766349792},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9279999732971191},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.9359999895095825},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.7599999904632568},{"id":"https://openalex.org/keywords/sensory-neuropathy","display_name":"sensory neuropathy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.746999979019165},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7860000133514404},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8560000061988831},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.5730000138282776},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5180000066757202},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4180000126361847},{"id":"https://openalex.org/keywords/stage-iiib","display_name":"stage IIIB","score":0.3709999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9398232698440552},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7246062159538269},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6761564612388611},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.6390048861503601},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5886085629463196},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5750669836997986},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5258198976516724},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.5037457346916199},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45537006855010986},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.45470696687698364},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41670554876327515},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4151979982852936},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36434632539749146},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3373429477214813},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3327195644378662},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.14086204767227173}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.7659","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7659","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.7659","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2164067249","https://openalex.org/W1971243106","https://openalex.org/W2603616054","https://openalex.org/W1984641154","https://openalex.org/W2600193862","https://openalex.org/W2796957233","https://openalex.org/W2153453251","https://openalex.org/W2123817154","https://openalex.org/W2149564448","https://openalex.org/W2570082522"],"abstract_inverted_index":{"7659":[0],"Background:":[1],"We":[2],"previously":[3,112],"reported":[4],"that":[5],"130-nM":[6],"albumin-bound":[7],"form":[8],"of":[9,21,42,58,80,92,126,139],"paclitaxel":[10,94,145],"(ABI-007,":[11],"nab":[12,144],"paclitaxel)":[13],"225":[14],"-":[15],"340":[16],"mg/m2":[17],"and":[18,55,60,71,122,142,179,230,235,257],"carboplatin":[19],"AUC":[20],"6":[22],"mg/min\u00b7ml":[23],"(C6),":[24],"both":[25],"administered":[26],"on":[27],"day":[28],"(d)":[29],"1":[30,171],"every":[31],"3":[32,72,133,148,236],"weeks":[33,129],"(q3w),":[34],"produced":[35],"an":[36],"objective":[37],"(PR/CR)":[38],"response":[39],"rate":[40],"(ORR)":[41],"27%":[43],"in":[44,95,99,176,198],"first":[45],"line":[46],"patients":[47],"(pts)":[48],"with":[49,51,89,97,111,119,251],"NSCLC":[50,100,118],"median":[52,163],"progression-free":[53],"(PFS)":[54],"overall":[56],"survivals":[57],"6.0":[59],">10.3":[61],"months":[62],"respectively":[63],"[Hawkins":[64],"et":[65],"al.,":[66],"ASCO,":[67],"2006].":[68],"Grade":[69,202,233],"2":[70,234],"sensory":[73],"neuropathy":[74,262],"(SN)":[75],"was":[76,84,174,238,255,259],"36\u201356%.":[77],"The":[78,192,213],"aim":[79],"the":[81,188,199,253],"current":[82],"study":[83],"to":[85,102,185,267],"obtain":[86],"clinical":[87,106],"experience":[88,270],"weekly":[90,146,264],"schedules":[91],"nab-":[93],"combination":[96],"C6":[98],"prior":[101,184],"initiating":[103],"large":[104],"scale":[105],"trials.":[107],"Methods:":[108],"75":[109,157],"Pts":[110],"untreated,":[113],"stage":[114],"IIIB":[115],"or":[116],"IV":[117],"measurable":[120],"disease":[121],"a":[123],"life":[124],"expectancy":[125],"over":[127],"12":[128],"were":[130,221],"recruited":[131],"into":[132],"cohorts":[134],"(n":[135],"=":[136],"25":[137],"each)":[138],"successive":[140],"pts":[141,158],"received":[143],"using":[147,271],"different":[149],"regimens":[150],"(see":[151],"table":[152,200],").":[153],"Results:":[154],"Patient":[155],"Characteristics:":[156],"(100%":[159],"Caucasian;":[160],"84%":[161],"male;":[162],"age,":[164],"60;":[165],"performance":[166],"status":[167],"score:":[168],"0":[169],"[16%],":[170],"[84%].":[172],"Accrual":[173],"completed":[175],"each":[177],"cohort":[178],"serious":[180],"adverse":[181],"events":[182],"reviewed":[183],"accrual":[186],"at":[187],"next":[189],"dose":[190],"level.":[191],"primary":[193],"efficacy":[194],"endpoints":[195],"are":[196],"provided":[197],".":[201],"3/4":[203],"hematologic":[204,217],"toxicities":[205,218],"were:":[206],"neutropenia":[207],"32%/35%;":[208],"thrombocytopenia,":[209],"19%/11%;":[210],"anemia,":[211],"24%/3%.":[212],"most":[214],"common":[215],"non-":[216],"(any":[219],"grade)":[220],"fatigue,":[222],"48%;":[223,225],"SN,":[224],"nausea,":[226],"37%;":[227],"alopecia,":[228],"40%;":[229],"vomiting,":[231],"26%.":[232],"SN":[237],"12\u201328%.":[239],"Graded":[240],"toxicity":[241],"data":[242],"by":[243],"regimen":[244],"will":[245],"be":[246],"presented.":[247],"Conclusions:":[248],"When":[249],"combined":[250],"C6,":[252],"ORR":[254],"higher":[256],"there":[258],"less":[260],"peripheral":[261],"for":[263],"nab-paclitaxel":[265],"compared":[266],"our":[268],"previous":[269],"q3w":[272],"administration.":[273],"[Table:":[274,277],"see":[275,278],"text]":[276,279]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2016-06-24T00:00:00"}